About
Technology
Issues
FAQ
Search
filter by year
2024 (3)
2023 (272)
2022 (514)
2021 (584)
2020 (663)
2010-2019 (3,303)
2000-2009 (1,370)
1990-1999 (485)
1980-1989 (224)
1970-1979 (127)
1960-1969 (85)
1950-1959 (70)
1900-1950 (108)
Similar Keywords
the (1,923)
merck (6,086)
1-20 of (8,009 documents found)
2016
6.3K
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine
(
13.9
★★★
), 375, 1823-1833.
Cite
Citations
Matthew Li (80, 6.9K)
2018
3.6K
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
New England Journal of Medicine
(
13.9
★★★
), 378, 2078-2092.
Cite
Citations
Matthew Li (80, 6.9K)
2015
4.5K
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
New England Journal of Medicine
(
13.9
★★★
), 372, 2018-2028.
Cite
Citations
Matthew Li (80, 6.9K)
2017
2.1K
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
New England Journal of Medicine
(
13.9
★★★
), 376, 1015-1026.
Cite
Citations
Matthew Li (80, 6.9K)
2015
2.7K
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
New England Journal of Medicine
(
13.9
★★★
), 372, 2387-2397.
Cite
Citations
Matthew Li (80, 6.9K)
2018
1.4K
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
New England Journal of Medicine
(
13.9
★★★
), 379, 2495-2505.
Cite
Citations
Matthew Li (80, 6.9K)
2018
1.1K
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
New England Journal of Medicine
(
13.9
★★★
), 378, 1789-1801.
Cite
Citations
Matthew Li (80, 6.9K)
2016
898
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
New England Journal of Medicine
(
13.9
★★★
), 374, 2542-2552.
Cite
Citations
Matthew Li (80, 6.9K)
2014
1.2K
Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
New England Journal of Medicine
(
13.9
★★★
), 371, 203-212.
Cite
Citations
Matthew Li (80, 6.9K)
2015
924
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
New England Journal of Medicine
(
13.9
★★★
), 372, 711-723.
Cite
Citations
Matthew Li (80, 6.9K)
2017
640
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
New England Journal of Medicine
(
13.9
★★★
), 377, 2433-2444.
Cite
Citations
Matthew Li (80, 6.9K)
2017
646
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
New England Journal of Medicine
(
13.9
★★★
), 377, 1217-1227.
Cite
Citations
Matthew Li (80, 6.9K)
2019
572
Defining ‘T cell exhaustion’
Nature Reviews Immunology
(
10.6
★★★
), 19, 665-674.
Cite
Citations
Matthew Li (80, 6.9K)
2017
538
Bezlotoxumab for Prevention of Recurrent
Clostridium difficile
Infection
New England Journal of Medicine
(
13.9
★★★
), 376, 305-317.
Cite
Citations
Matthew Li (80, 6.9K)
2018
421
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
New England Journal of Medicine
(
13.9
★★★
), 378, 1691-1703.
Cite
Citations
Matthew Li (80, 6.9K)
2011
816
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
New England Journal of Medicine
(
13.9
★★★
), 364, 401-411.
Cite
Citations
Matthew Li (80, 6.9K)
2012
718
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
New England Journal of Medicine
(
13.9
★★★
), 366, 1404-1413.
Cite
Citations
Matthew Li (80, 6.9K)
2021
255
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
New England Journal of Medicine
(
13.9
★★★
), 385, 683-694.
Cite
Citations
Matthew Li (80, 6.9K)
2012
606
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
New England Journal of Medicine
(
13.9
★★★
), 366, 20-33.
Cite
Citations
Matthew Li (80, 6.9K)
2011
689
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
New England Journal of Medicine
(
13.9
★★★
), 365, 1576-1585.
Cite
Citations
Matthew Li (80, 6.9K)
1
2
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.